Repository logo
 

Associations between a fetal imprinted gene allele score and late pregnancy maternal glucose concentrations

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Petry, CJ 
Mooslehner, K 
Prentice, P 
Hayes, MG 
Nodzenski, M 

Abstract

Aim

We hypothesised that some of the genetic risk for gestational diabetes (GDM) is due to the fetal genome affecting maternal glucose concentrations. Previously, we found associations between fetal IGF2 gene variants and maternal glucose concentrations in late pregnancy.

Methods

In the present study, we tested associations between SNP alleles from 15 fetal imprinted genes and maternal glucose concentrations in late pregnancy in the Cambridge Baby Growth and Wellbeing cohorts (1160 DNA trios).

Results

Four fetal SNP alleles with the strongest univariate associations: paternally-transmitted IGF2 rs10770125 (P-value = 2 × 10−4) and INS rs2585 (P-value = 7 × 10−4), and maternally-transmitted KCNQ1(OT1) rs231841 (P-value = 1 × 10−3) and KCNQ1(OT1) rs7929804 (P-value = 4 × 10−3), were used to construct a composite fetal imprinted gene allele score which was associated with maternal glucose concentrations (P-value = 4.3 × 10−6, n = 981, r2 = 2.0%) and GDM prevalence (odds ratio per allele 1.44 (1.15, 1.80), P-value = 1 × 10−3, n = 89 cases and 899 controls). Meta-analysis of the associations including data from 1367 Hyperglycaemia and Adverse Pregnancy Outcome Study participants confirmed the paternally-transmitted fetal IGF2/INS SNP associations (rs10770125, P-value = 3.2 × 10−8, rs2585, P-value = 3.6 × 10−5) and the composite fetal imprinted gene allele score association (P-value = 1.3 × 10−8), but not the maternally-transmitted fetal KCNQ1(OT1) associations (rs231841, P-value = 0.4; rs7929804, P-value = 0.2).

Conclusion

This study suggests that polymorphic variation in fetal imprinted genes, particularly in the IGF2/INS region, contribute a small but significant part to the risk of raised late pregnancy maternal glucose concentrations.

Description

Keywords

gestational diabetes, KCNQ1, meta-analysis, placenta

Journal Title

Diabetes & Metabolism

Conference Name

Journal ISSN

1262-3636
1878-1780

Volume Title

Publisher

Elsevier
Sponsorship
MRC Epidemiology Unit (7500001180)
Medical Research Council (MC_UU_12015/2)
National Institute for Health Research (NIHR) (via West Anglia Comprehensive Local Research Network (CLRN)) (UKCRN 11822)
Cambridge University Hospitals NHS Foundation Trust (CUH)
NIHR Clinical Research Network Eastern (IRAS 67546 REC Ref: 11/EE/0068)
Biotechnology and Biological Sciences Research Council (BB/F02293X/1)
Medical Research Council (G0600717)
Medical Research Council (G1001995)
Medical Research Council (G0500733)
Diabetes UK (11/0004241)
Medical Research Council (G1001995/1)
Medical Research Council (G0500733/1)
Medical Research Council (G0600717/1)
This work was supported by the Evelyn Trust (grant number EW9035322); Diabetes UK (grant number 11/0004241); the Wellbeing of Women (the Royal College of Obstetricians and Gynaecologists, UK) (grant number RG1644); the Medical Research Council (grant number 7500001180); European Union Framework 5 (grant number QLK4-1999-01422); the Mothercare Charitable Foundation (grant number RG54608); Newlife Foundation for Disabled Children (grant number 07/20); the World Cancer Research Fund International (grant number 2004/03); and the National Institute for Health Research Cambridge Biomedical Research Centre. The HAPO Study work was supported by the National Institutes of Health (grant numbers HD-34242, HD-34243, HG-004415, and CA-141688); the Institutes of Health Research–INMD (grant number 110791); and by the American Diabetes Association.
Relationships
Is supplemented by: